Brimonidine as a possible treatment for myopia

BMC Ophthalmology

Table 1 Groups

Group	Treatment	Numbers
A	None	6
B	FDM Only	6
C1	FDM+2µg/µL brimonidine eyedrops, one drop	6
C2	FDM+4µg/µL brimonidine eyedrops, one drop	6
C3	FDM+20µg/µL brimonidine eyedrops, one drop	6
C4	FDM+40µg/µL brimonidine eyedrops, one drop	6
C5	FDM+PBS, one drop	6
D1	FDM+2µg/µL brimonidine subconjunctivally, 5µL	6
D2	FDM+4µg/µL brimonidine subconjunctivally, 5µL	6
D3	FDM+20µg/µL brimonidine subconjunctivally,5µL	7
D4	FDM+40µg/µL brimonidine subconjunctivally, 5µL	6
D5	FDM+PBS, 5µL	6
E1	FDM+2µg/µL brimonidine intravitreally, 5µL	7
E2	FDM+4µg/µL brimonidine intravitreally, 5µL	7
E3	FDM+20µg/µL brimonidine intravitreally, 5µL	6
E4	FDM+40µg/µL brimonidine intravitreally, 5µL	6
E5	FDM+PBS, 5µL	6

ISSN: 1471-2415